These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 12751207)
21. Detection of Epstein-Barr virus DNA in plasma/serum: a useful serological indicator for diagnosis of nasopharyngeal carcinoma. Mai S; Zong Y; Zhang M; Zhong B; Lin S Chin Med J (Engl); 2002 Dec; 115(12):1895-7. PubMed ID: 12622949 [TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus detection in nasopharyngeal tissues of patients with suspected nasopharyngeal carcinoma. Tsai ST; Jin YT; Mann RB; Ambinder RF Cancer; 1998 Apr; 82(8):1449-53. PubMed ID: 9554519 [TBL] [Abstract][Full Text] [Related]
23. Association between EBNA2 and LMP1 subtypes of Epstein-Barr virus and nasopharyngeal carcinoma in Thais. Tiwawech D; Srivatanakul P; Karalak A; Ishida T J Clin Virol; 2008 May; 42(1):1-6. PubMed ID: 18180201 [TBL] [Abstract][Full Text] [Related]
24. Epstein-Barr viral DNA in serum of patients with nasopharyngeal carcinoma. Mutirangura A; Pornthanakasem W; Theamboonlers A; Sriuranpong V; Lertsanguansinchi P; Yenrudi S; Voravud N; Supiyaphun P; Poovorawan Y Clin Cancer Res; 1998 Mar; 4(3):665-9. PubMed ID: 9533535 [TBL] [Abstract][Full Text] [Related]
25. Screening nasopharyngeal carcinoma by detection of the latent membrane protein 1 (LMP-1) gene with nasopharyngeal swabs. Hao SP; Tsang NM; Chang KP Cancer; 2003 Apr; 97(8):1909-13. PubMed ID: 12673717 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of commercial EBV RecombLine assay for diagnosis of nasopharyngeal carcinoma. Paramita DK; Fachiroh J; Haryana SM; Middeldorp JM J Clin Virol; 2008 Aug; 42(4):343-52. PubMed ID: 18455473 [TBL] [Abstract][Full Text] [Related]
27. [The clinical value of quantitative analysis of plasma Epstein-Barr virus DNA in patients with nasopharyngeal carcinoma]. Yuan H; Yang BB; Xu ZF Zhonghua Er Bi Yan Hou Ke Za Zhi; 2004 Mar; 39(3):162-5. PubMed ID: 15283296 [TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr virus infection in precursor lesions of nasopharyngeal carcinoma. Zhong BL; Zong YS; Lin SX; Zhang M; Liang YJ Ai Zheng; 2006 Feb; 25(2):136-42. PubMed ID: 16480574 [TBL] [Abstract][Full Text] [Related]
29. [Quantitative and localized detection of Epstein-Barr virus infectious status in nasopharyngeal carcinoma tissue]. Jiang WH; Zhao SP; Yin ZH; Li F; Chen ZH; Xiao JY Ai Zheng; 2005 Jul; 24(7):796-800. PubMed ID: 16004803 [TBL] [Abstract][Full Text] [Related]
30. Quantification of plasma Epstein-Barr virus DNA in patients with advanced nasopharyngeal carcinoma. Lin JC; Wang WY; Chen KY; Wei YH; Liang WM; Jan JS; Jiang RS N Engl J Med; 2004 Jun; 350(24):2461-70. PubMed ID: 15190138 [TBL] [Abstract][Full Text] [Related]
31. Telomerase assay and nested polymerase chain reaction from nasopharyngeal swabs for early noninvasive detection of nasopharyngeal carcinoma. Kerekhanjanarong V; Sitawarin S; Sakdikul S; Saengpanich S; Chindavijak S; Supiyaphun P; Voravud N; Mutirangura A Otolaryngol Head Neck Surg; 2000 Nov; 123(5):624-9. PubMed ID: 11077353 [TBL] [Abstract][Full Text] [Related]
32. Clinical evaluation of a quantitative real time polymerase chain reaction assay for diagnosis of primary Epstein-Barr virus infection in children. Pitetti RD; Laus S; Wadowsky RM Pediatr Infect Dis J; 2003 Aug; 22(8):736-9. PubMed ID: 12913777 [TBL] [Abstract][Full Text] [Related]
33. Quantitative analysis of the transrenal excretion of circulating EBV DNA in nasopharyngeal carcinoma patients. Chan KC; Leung SF; Yeung SW; Chan AT; Lo YM Clin Cancer Res; 2008 Aug; 14(15):4809-13. PubMed ID: 18676752 [TBL] [Abstract][Full Text] [Related]
34. [Correlation between the kinetics of plasma EBV DNA levels and clinical response during treatment in patients with nasopharyngeal carcinoma]. Peng PJ; Zhao C; Liao H; Wang FQ; Zhang L Ai Zheng; 2002 Aug; 21(8):817-22. PubMed ID: 12478884 [TBL] [Abstract][Full Text] [Related]
35. Prevalence of the Taiwan variant of the Epstein-Barr virus in nasopharyngeal carcinoma patients and normal individuals. Shu CH; Tu TY Zhonghua Yi Xue Za Zhi (Taipei); 2000 Apr; 63(4):288-93. PubMed ID: 10820907 [TBL] [Abstract][Full Text] [Related]
36. Comparison of the prognostic impact of serum anti-EBV antibody and plasma EBV DNA assays in nasopharyngeal carcinoma. Twu CW; Wang WY; Liang WM; Jan JS; Jiang RS; Chao J; Jin YT; Lin JC Int J Radiat Oncol Biol Phys; 2007 Jan; 67(1):130-7. PubMed ID: 16979842 [TBL] [Abstract][Full Text] [Related]
37. A comparison study of different PCR assays in measuring circulating plasma epstein-barr virus DNA levels in patients with nasopharyngeal carcinoma. Le QT; Jones CD; Yau TK; Shirazi HA; Wong PH; Thomas EN; Patterson BK; Lee AW; Zehnder JL Clin Cancer Res; 2005 Aug; 11(16):5700-7. PubMed ID: 16115906 [TBL] [Abstract][Full Text] [Related]
38. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma. Chang KP; Hsu CL; Chang YL; Tsang NM; Chen CK; Lee TJ; Tsao KC; Huang CG; Chang YS; Yu JS; Hao SP Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420 [TBL] [Abstract][Full Text] [Related]
39. Real-time polymerase chain reaction quantification of human cytomegalovirus and Epstein-Barr virus in periodontal pockets and the adjacent gingiva of periodontitis lesions. Kubar A; Saygun I; Ozdemir A; Yapar M; Slots J J Periodontal Res; 2005 Apr; 40(2):97-104. PubMed ID: 15733143 [TBL] [Abstract][Full Text] [Related]
40. Distribution of Epstein-Barr virus genotypes in throat washings, sera, peripheral blood lymphocytes and in EBV positive tumor biopsies from Slovenian patients with nasopharyngeal carcinoma. Klemenc P; Marin J; Soba E; Gale N; Koren S; Strojan P J Med Virol; 2006 Aug; 78(8):1083-90. PubMed ID: 16789009 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]